# SGA-induced Metabolic Syndrome in Bipolar Youth

> **NCT01858948** · PHASE3 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 19 (actual)

## Conditions studied

- Bipolar Youth Treated With Second-generation Antipsychotics

## Interventions

- **DRUG:** Omega
- **DRUG:** Placebo
- **DRUG:** Quetiapine fumarate

## Key facts

- **NCT ID:** NCT01858948
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2022-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858948, "SGA-induced Metabolic Syndrome in Bipolar Youth". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01858948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*